Atlas Trials

A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation

Clinical trial NCT02988674 · COMPLETED

Trial details

NCT number
NCT02988674
Sponsor
AbbVie
Status
COMPLETED
Study type
OBSERVATIONAL
SpondylarthritisPsoriatic ArthritisAnkylosing Spondylitis (AS)
Start date
2016-12-22
Primary completion
2019-10-16
Enrollment
139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.